Berkeley Capital Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,891
| Closed | -$576K | – | 156 |
|
|
2021
Q4 | $576K | Sell |
9,891
-548
| -5% | -$31.9K | 0.24% | 68 |
|
|
2021
Q3 | $627K | Sell |
10,439
-162
| -2% | -$9.73K | 0.29% | 57 |
|
|
2021
Q2 | $635K | Buy |
10,601
+1,020
| +11% | +$61.1K | 0.28% | 54 |
|
|
2021
Q1 | $476K | Buy |
9,581
+6
| +0.1% | +$298 | 0.23% | 66 |
|
|
2020
Q4 | $479K | Sell |
9,575
-195
| -2% | -$9.76K | 0.25% | 63 |
|
|
2020
Q3 | $535K | Sell |
9,770
-1,703
| -15% | -$93.3K | 0.33% | 47 |
|
|
2020
Q2 | $607K | Sell |
11,473
-5,728
| -33% | -$303K | 0.37% | 45 |
|
|
2020
Q1 | $768K | Sell |
17,201
-2,975
| -15% | -$133K | 0.52% | 38 |
|
|
2019
Q4 | $1.01M | Sell |
20,176
-739
| -4% | -$36.8K | 0.52% | 43 |
|
|
2019
Q3 | $932K | Sell |
20,915
-723
| -3% | -$32.2K | 0.49% | 44 |
|
|
2019
Q2 | $893K | Buy |
21,638
+321
| +2% | +$13.2K | 0.42% | 47 |
|
|
2019
Q1 | $862K | Sell |
21,317
-3,298
| -13% | -$133K | 0.43% | 50 |
|
|
2018
Q4 | $935K | Sell |
24,615
-2,246
| -8% | -$85.3K | 0.52% | 39 |
|
|
2018
Q3 | $1.06M | Sell |
26,861
-6,087
| -18% | -$241K | 0.6% | 38 |
|
|
2018
Q2 | $1.16M | Sell |
32,948
-5,457
| -14% | -$191K | 0.68% | 31 |
|
|
2018
Q1 | $1.34M | Sell |
38,405
-7,792
| -17% | -$272K | 0.78% | 24 |
|
|
2017
Q4 | $1.6M | Buy |
46,197
+3,851
| +9% | +$134K | 1.06% | 18 |
|
|
2017
Q3 | $1.44M | Buy |
42,346
+7,702
| +22% | +$261K | 0.96% | 20 |
|
|
2017
Q2 | $1.18M | Buy |
34,644
+1,233
| +4% | +$42K | 0.8% | 24 |
|
|
2017
Q1 | $1.04M | Sell |
33,411
-13,900
| -29% | -$433K | 0.71% | 30 |
|
|
2016
Q4 | $1.29M | Buy |
47,311
+17,002
| +56% | +$465K | 0.93% | 22 |
|
|
2016
Q3 | $996K | Sell |
30,309
-4,220
| -12% | -$139K | 0.71% | 30 |
|
|
2016
Q2 | $1.04M | Buy |
+34,529
| New | +$1.04M | 0.73% | 28 |
|